Univation Technologies announces launch of the UNIGILITY™ Tubular High Pressure PE Process Technology as a licensed platform for production of LDPE and EVA resins

HOUSTON, June 16, 2024 /PRNewswire/ — Univation Technologies, LLC announces the launch of its latest licensed…

Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will host an investor…

BMEA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights By Investing.com

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law…

Empire State Building Debuts 270-Foot Vhagar the Dragon Coiled Around the Building’s Mast, in Partnership with Max By Investing.com

The massive dragon caps off the weeklong House of the Dragon takeover at the Observatory NEW…

Michael Saylor Makes Epic Bitcoin Call Amid Market Lull: Details By U.Today

U.Today – Michael Saylor, chairman and cofounder of MicroStrategy, has made an epic call to the…

Fed’s Kashkari says ‘reasonable’ to predict December rate cut By Reuters

(Reuters) – Minneapolis Federal Reserve President Neel Kashkari on Sunday said it’s a “reasonable prediction” that…

Fourteen Jordanians die during haj in Saudi Arabia, some succumb to heat By Reuters

CAIRO (Reuters) – Fourteen Jordanians have been reported dead during the annual Muslim haj pilgrimage in…

Legendary Trader Peter Brandt Endorses Satoshi Nakamoto’s Bitcoin Vision By U.Today

U.Today – One of the most experienced traders among cryptocurrency enthusiasts, Peter Brandt, has shared an…

Israeli military announces tactical pauses in Gaza for aid supplies By Reuters

JERUSALEM (Reuters) -The Israeli military said on Sunday it would hold daily tactical pauses in military…

CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial

First and only BTK inhibitor to demonstrate favorable overall survival trend vs. standard-of-care chemoimmunotherapy in this…